Leonard J. Nelson

Edinburgh, SCT, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Deciphering cytochrome P450 reductase role in MASLD: molecular mechanisms and pathophysiological implications.

Deciphering cytochrome P450 reductase role in MASLD: molecular mechanisms and pathophysiological implications.

Journal: Nature reviews. Gastroenterology & hepatology

Published: March 25, 2026

Multi-cell, non-invasive, online monitoring of PLA-coated magnetic nanoparticles uptake by MCF-7 cells using digital holographic microscopy.

Multi-cell, non-invasive, online monitoring of PLA-coated magnetic nanoparticles uptake by MCF-7 cells using digital holographic microscopy.

Journal: Bioactive materials

Published: November 05, 2025

Control compounds for preclinical drug-induced liver injury assessment: Consensus-driven systematic review by the ProEuroDILI network.

Control compounds for preclinical drug-induced liver injury assessment: Consensus-driven systematic review by the ProEuroDILI network.

Journal: Journal of hepatology

Published: February 14, 2024

Roadmap to DILI research in Europe. A proposal from COST action ProEuroDILINet.

Roadmap to DILI research in Europe. A proposal from COST action ProEuroDILINet.

Journal: Pharmacological research

Published: November 07, 2023

Non-invasive methods of monitoring Fe3O4 magnetic nanoparticle toxicity in human liver HepaRG cells using impedance biosensing and Coherent anti-Stokes Raman spectroscopic (CARS) microscopy.

Non-invasive methods of monitoring Fe3O4 magnetic nanoparticle toxicity in human liver HepaRG cells using impedance biosensing and Coherent anti-Stokes Raman spectroscopic (CARS) microscopy.

Journal: Toxicology letters

Published: September 30, 2023

Lack of Cyclin E1 in hepatocytes aggravates ethanol-induced liver injury and hepatic steatosis in experimental murine model of acute and chronic alcohol-associated liver disease.

Lack of Cyclin E1 in hepatocytes aggravates ethanol-induced liver injury and hepatic steatosis in experimental murine model of acute and chronic alcohol-associated liver disease.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: September 13, 2022

New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming.

New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming.

Journal: Journal of experimental & clinical cancer research : CR

Published: April 05, 2022

Activation of the Unfolded Protein Response (UPR) Is Associated with Cholangiocellular Injury, Fibrosis and Carcinogenesis in an Experimental Model of Fibropolycystic Liver Disease.

Activation of the Unfolded Protein Response (UPR) Is Associated with Cholangiocellular Injury, Fibrosis and Carcinogenesis in an Experimental Model of Fibropolycystic Liver Disease.

Journal: Cancers

Published: December 02, 2021

Genetic and pharmacological inhibition of XBP1 protects against APAP hepatotoxicity through the activation of autophagy.

Genetic and pharmacological inhibition of XBP1 protects against APAP hepatotoxicity through the activation of autophagy.

Journal: Cell death & disease

Published: July 05, 2021

Next-generation sequencing of bile cell-free DNA for the early detection of patients with malignant biliary strictures.

Next-generation sequencing of bile cell-free DNA for the early detection of patients with malignant biliary strictures.

Journal: Gut

Published: May 15, 2021

Advanced preclinical models for evaluation of drug-induced liver injury - consensus statement by the European Drug-Induced Liver Injury Network [PRO-EURO-DILI-NET].

Advanced preclinical models for evaluation of drug-induced liver injury - consensus statement by the European Drug-Induced Liver Injury Network [PRO-EURO-DILI-NET].

Journal: Journal of hepatology

Published: April 20, 2021

Fibrotic Events in the Progression of Cholestatic Liver Disease.

Fibrotic Events in the Progression of Cholestatic Liver Disease.

Journal: Cells

Published: April 13, 2021

Showing 1-12 of 34

Last Updated: 09/26/2026